Table 1.
Baseline characteristics of the study population
| Characteristic | Oxymetholone (n=19) | Placebo (n=22) |
|---|---|---|
| Age (yr) | 41.0±10.5 | 45.1±8.5 |
| Number of males (%) | 10 (52.6) | 15 (68.2) |
| Dry weight (kg) | 54.4±8.8 | 56.8±8.9 |
| Median dialysis vintage (mo; IQR) | 98.0 (61.0–110.0) | 96.0 (59.0–115.7) |
| Body mass index (kg/m2) | 21.6±3.2 | 21.2±3.5 |
| Single-pool Kt/V urea | 1.9±0.3 | 1.8±0.2 |
| Predialysis SBP (mmHg) | 139.9±15.1 | 139.0±10.4 |
| Predialysis DBP (mmHg) | 78.6±6.1 | 79.6±4.3 |
| Causes of ESRD (n [%]) | ||
| Chronic glomerulonephritis | 6 (31.6) | 6 (27.3) |
| Hypertension | 3 (15.8) | 3 (13.6) |
| IgA nephropathy | 1 (5.3) | 3 (13.6) |
| Other causes | 3 (15.8) | 2 (9.1) |
| Unknown | 6 (31.6) | 8 (36.4) |
Data are mean ± SD. IQR, interquartile range; SBP, systolic BP; DBP, diastolic BP.